These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1812709)

  • 1. Crystal structures of rhizopuspepsin/inhibitor complexes.
    Parris KD; Hoover DJ; Davies DR
    Adv Exp Med Biol; 1991; 306():217-31. PubMed ID: 1812709
    [No Abstract]   [Full Text] [Related]  

  • 2. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
    Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
    Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
    Ringe D
    Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and function of a pepstatin-insensitive acid proteinase from Aspergillus niger var. Macrosporus.
    Takahashi K; Tanokura M; Inoue H; Kojima M; Muto Y; Yamasaki M; Makabe O; Kimura T; Takizawa T; Hamaya T
    Adv Exp Med Biol; 1991; 306():203-11. PubMed ID: 1812707
    [No Abstract]   [Full Text] [Related]  

  • 5. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
    Suguna K; Padlan EA; Bott R; Boger J; Parris KD; Davies DR
    Proteins; 1992 Jul; 13(3):195-205. PubMed ID: 1603809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pepstatin-insensitive carboxyl proteinases.
    Oda K; Murao S
    Adv Exp Med Biol; 1991; 306():185-201. PubMed ID: 1812706
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes.
    Parris KD; Hoover DJ; Damon DB; Davies DR
    Biochemistry; 1992 Sep; 31(35):8125-41. PubMed ID: 1525154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.
    Kamitori S; Ohtaki A; Ino H; Takeuchi M
    J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
    Kuzmic P; Sun CQ; Zhao ZC; Rich DH
    Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
    [No Abstract]   [Full Text] [Related]  

  • 10. Extracellular aspartic proteinases from Candida yeasts.
    Fusek M; Smith E; Foundling SI
    Adv Exp Med Biol; 1995; 362():489-500. PubMed ID: 8540363
    [No Abstract]   [Full Text] [Related]  

  • 11. Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp.
    Sun Y; Takada K; Nogi Y; Okada S; Matsunaga S
    J Nat Prod; 2014 Jul; 77(7):1749-52. PubMed ID: 24960234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of endothiapepsin complexed with the gem-diol inhibitor PD-135,040 at 1.37 A.
    Coates L; Erskine PT; Mall S; Williams PA; Gill RS; Wood SP; Cooper JB
    Acta Crystallogr D Biol Crystallogr; 2003 Jun; 59(Pt 6):978-81. PubMed ID: 12777758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.
    Lowther WT; Majer P; Dunn BM
    Protein Sci; 1995 Apr; 4(4):689-702. PubMed ID: 7613467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors.
    Cooper J; Quail W; Frazao C; Foundling SI; Blundell TL; Humblet C; Lunney EA; Lowther WT; Dunn BM
    Biochemistry; 1992 Sep; 31(35):8142-50. PubMed ID: 1525155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human napsin A.
    Cronshaw RF; Schauer-Vukasinovic V; Powell DJ; Giller T; Bur D; Kay J
    Protein Pept Lett; 2003 Feb; 10(1):35-42. PubMed ID: 12625824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of aspartic proteases. IV.Conformational characteristics of a substrate and an inhibitor of rhizopuspepsin ].
    Kashparov IV; Popov ME; Popov EM
    Bioorg Khim; 1999 Jun; 25(6):423-34. PubMed ID: 10505230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of inhibited aspartic proteinase from Candida albicans.
    Cutfield S; Marshall C; Moody P; Sullivan P; Cutfield J
    J Mol Biol; 1993 Dec; 234(4):1266-9. PubMed ID: 8263928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.
    Lunney EA; Hamilton HW; Hodges JC; Kaltenbronn JS; Repine JT; Badasso M; Cooper JB; Dealwis C; Wallace BA; Lowther WT
    J Med Chem; 1993 Nov; 36(24):3809-20. PubMed ID: 8254610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based prediction of binding affinities and molecular design of peptide ligands.
    Luque I; Freire E
    Methods Enzymol; 1998; 295():100-27. PubMed ID: 9750216
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK; Kulkarni VM
    Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.